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Decellularized extracellular matrices (dECMs) are considered ideal scaffolds for tissue 
regeneration due to their inherent bioactivity. Despite this advantage, the use of dECMs for 
bladder tissue reconstruction has resulted in inconsistent preclinical model results, including 
complications such as infection, stone formation, and loss in bladder capacity. These results have 
been attributed to a mismatch in material properties and the mechanical requirements of the 
bladder; most notable is the ability to undergo large expansion under minimally applied force.  
Here, we present the first study to improve dECM compliance through chemical 
modification, in order to meet the mechanical functional requirements of the bladder. Aliphatic 
chains (C18) were incorporated onto porcine small intestinal submucosa (SIS), porcine urinary 
bladder matrix (UBM), bovine pericardium, bovine dermis, and human dermis scaffolds. The 
effect of hydrophobe addition on scaffold physical properties, cytotoxicity and immune response 
was studied. Modified materials exhibited compliance that was comparable to rabbit bladder 
tissue. Material toughness, evaluated through uniaxial tensile testing, and resistance to 
enzymatic degradation, specifically collagenase I, increased with minimal change in the swelling 
profile at 37oC. Direct contact angle measurements were used to investigate surface 
hydrophobicity and this was found to increase with C18 addition for all dECMs. Human bladder 
epithelial cells seeded directly on dECMs preferentially adhered to moderately hydrophobic 
surfaces compared to human bladder fibroblasts and THP-1 macrophages. Modified dECM 
scaffolds also exhibited improved immunomodulatory capacity, with upregulation of TGF and 
CD163 and downregulation of TNF and CD86 in macrophages, evaluated in vitro using RT-qPCR. 
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Cell infiltration to the biomaterial center and biomaterial degradation in vivo, observed in 
subcutaneously implanted dECMs, were delayed upon C18 modification at Day 7 but did not 
show signs of causing graft rejection by Day 21. 
Of all dECMs tested, modified bovine pericardium demonstrated the largest improvement 
in material compliance, the capacity to support cell adhesion, and the greatest shift in 
macrophage behavior towards a pro-regenerative M2 phenotype. The enhanced compliance of 
modified materials and favourable immune response suggest that C18-modified dECMs are 
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Bladder dysfunction caused by impaired bladder tissue frequently calls for reconstructive 
surgeries to prevent injury to the kidneys and the build-up of toxins in the blood1. The most 
common procedure, bladder augmentation using gastrointestinal segments, often results in 
complications including bacterial infection, stone formation and inflammation1–3. It is speculated 
that these issues are caused by differences in the tissue structure and function of the native 
bladder tissue and repurposed gastrointestinal segments. Alternative tissue engineering 
strategies for reconstructive urology have evolved over the last several decades, including the 
use of different biomaterials, acellular and cell-laden scaffolds, with varying levels of clinical 
success4–7. Thus, there is still a need for the development of a biomaterial suitable for bladder 
tissue regeneration.  
The primary function of the bladder must be considered to guide biomaterial design; the 
biomaterial, and eventually the newly formed bladder tissue, must be able to support liquid 
storage, maintain the blood-urine barrier, and withstand cyclic loading and unloading1,4,8. In 
addition to having compatible mechanical properties, the ideal scaffold for regenerative 
medicine supports cell-matrix interactions for tissue regrowth and modulates the host immune 
system to give rise to a pro-regenerative environment5. Increased understanding of the immune 
response has shifted design criteria towards promoting interactions between the material and 
the immune system that elicit a desired response, rather than aiming for the development of an 
“inert” material. The interactions between scaffolds and cells of the innate immune system, 
namely dendritic cells, eosinophils, macrophages and NK cells, have been studied to assess the 
foreign body response in vitro and in vivo because of their roles in early wound healing and 
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influence on the adaptive immune cell phenotype9–11. Macrophages are of special interest in 
tissue engineering because of their plasticity; in response to external stimuli, such as a newly 
implanted biomaterial, these cells differentiate into functional states that exist along a spectrum 
ranging from a pro-inflammatory or classically activated phenotype (“M1”) to a pro-regenerative 
or alternatively activated (“M2”) phenotype12. This phenotypic response alters the surface 
marker expression and cytokine production that influences the response of other innate immune 
cells, other tissue resident cells, as well as adaptive immune cells, namely T-cells and B-cells. 
Therefore, macrophages are frequently used to study the effects of material stiffness, 
microarchitecture and surface chemistry on their differentiation as an indicator of the host 
immune response13–15. 
Scaffolds derived from decellularized extracellular matrix (dECM) have been extensively 
studied as viable scaffolds for tissue regeneration. Bioactive molecules, such as growth factors 
and proteoglycans, naturally present in live tissue survive the decellularization process and serve 
to induce tissue regrowth, making dECM a particularly attractive biomaterial scaffold for 
regenerative medicine4,16. A variety of sources have been used and approved by the FDA for 
urologic surgeries including small intestinal submucosa (SIS), pericardium, and urinary bladder 
matrix (UBM); however, these materials are not approved for urologic tissue regeneration. Many 
researchers have reported successfully regenerated urothelium, muscle layers, and complete 
vascularization in pre-clinical models while others have observed graft contracture, 
inflammation, and urine leakage3,5. These complications have been attributed to poorly matched 
mechanical properties; for example, poor distensibility or rapid scaffold degradation prior to 
urothelium regeneration17,18.  Efforts have been made to produce dECM scaffolds for load-
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bearing tissue regeneration by tuning the mechanical strength through chemical crosslinkers. 
However, the use of such crosslinking agents has caused increased immunogenicity and reduced 
scaffold elasticity, a key property required for proper bladder tissue function19–21. Instead, other 
strategies have been employed to strengthen dECMs while maintaining favourable cellular 
interactions. Ge et al. modified UBM scaffolds with a dopamine coating to improve scaffold 
strength for urological applications22. Improvement of strength was observed through higher 
break force required and reduced degradation; however, material elasticity was not tested, and 
scaffold strength was not contextualized in terms of the bladder. Alternatively, Roth et al. 
incorporated nanoparticles in SIS scaffolds to reduce their permeability and prevent urine 
leakage; slight improvements in smooth muscle regeneration did not serve to improve bladder 
capacity post-surgery23. In an attempt to reduce chronic inflammation and fibrosis, dECM 
scaffolds have been loaded with additional growth factors for slow release in vivo. Some 
inhibition of graft contracture was achieved, but no significant differences were observed in 
terms of tissue regeneration24. As such, a modified dECM scaffold that meets the aforementioned 
design requirements remains elusive. 
Synthetic polymer hydrogels, while attractive alternatives to naturally-derived scaffolds 
because of their reproducibility and tunability, have been found to have limited success in the 
regeneration of load-bearing tissues25. Abdurrahmanoglu et al. demonstrated that long, 
hydrophobic molecules can act as transient crosslinkers that enhance energy dissipation through 
reversible non-covalent bonding upon addition to polymer hydrogels26. This phenomenon has 
led to the development of high strength, viscoelastic hydrogels with self-healing abilities25,27,28. 
Additionally, a study on aliphatic n-alkanols conducted by Carignan et al. concluded that the 
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immunomodulatory impact of these molecules is correlated with their hydrophobicity29. Inspired 
by these findings, we developed a methodology that creates elastomeric collagen gels through 
the integration of aliphatic chains30. We investigated a series of aliphatic chains of varying lengths 
and found a C18 hydrophobe to result in the most improvement in the compliance of naturally-
derived hydrogels. We aim to test this method further using various dECMs in order to create 
tougher, compliant scaffolds without the use of traditional crosslinking agents. We hypothesize 
that the addition of aliphatic chains will improve scaffold survival in vivo by reducing degradation 
rates and promoting a pro-regenerative immune cell phenotype; in conjunction with the 
naturally present biological cues, these modified dECM scaffolds may be better suited to 
generate biomechanically functional bladder tissue. Five different dECMs were modified in this 
study and evaluated for further pre-clinical studies using the following design aspects: their 
mechanical and physical properties post-modification, their ability to support cell adhesion and 
proliferation, and material immunogenicity. Here, we investigate the potential for dECMs 










2 Experimental Methods 
 
2.1 dECM Scaffold Source 
 
Five different dECM scaffolds from different tissue sources were chosen to be studied. 
None of the scaffolds chosen were crosslinked prior to purchasing. The Cook Biodesign 4-layer 
tissue graft was chosen to study porcine SIS and the porcine UBM scaffold studied was the ACell 
Matristem Bladder Matrix Sheet, both obtained from the vendor, esutures.com. The Bovine 
Pericardium Dural Graft was purchased from Integra LifeSciences. The Integra Surgimend 1.0 
Acellular matrix and the Humend 1.0 Acellular matrix were purchased to study bovine dermis and 
human dermis, respectively. Both dECM materials were also procured from esutures.com.    
 
2.2 dECM Scaffold Modification  
 
dECM scaffolds were chemically modified using Isooctadecenylsuccinic anhydride (C18) 
obtained from TCI Chemicals. A C18 solution was diluted to 20 mg/mL in DMSO (Thermofisher). 
Prior to reaction, dECM scaffolds were soaked in PBS (pH 7.4) for 15 minutes; excess liquid was 
removed, and the scaffold was submerged in 20 mg/mL C18 in dimethyl sulfoxide (DMSO). 
Scaffold in solution was left on a rotator at room temperature for either 1 or 2 hours. After the 
designated reaction time, modified scaffolds were taken out of DMSO and washed 3 times in PBS 
for 5 minutes each wash. dECM scaffolds were also thermally denatured to further compare the 
mechanical properties. To do so, samples were soaked in PBS for 15 minutes at room 
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temperature (RT) prior to being transferred to incubated at 65oC for 2 hours. Scaffolds were then 
left to cool at RT and dried overnight.  
 
2.3 Mechanical Testing  
 
Uniaxial tensile testing was performed using the MTS Criterion Model 43 and a 100N load 
cell with a constant strain rate of 1 mm/min. Rectangular samples of ECM (n=3 per group) and 
rabbit bladder tissue (n=3) were placed in a paper-based custom apparatus to provide proper 
grip during experiments. Sample width, length and height prior to testing were recorded and 
used to calculate tensile strength, material toughness and linear elastic moduli at 0-20% strain 
and 0-100% strain. Data was recorded and processed using Microsoft Excel, R, and Prism 8.0 
software programs.  
 
2.4 Swelling Ratio, Enzymatic Degradation and Contact Angle Measurements 
 
Dry weights of unmodified and modified dECM scaffolds were measured for each sample 
(n=3 per group per material) and kept in PBS (pH 7.4) at 37oC. Wet weights were measured at 
t=0, 1, 2, 3, 4, 6 and 24 hours. The swelling ratio of each sample was plotted over time where 
swelling ratio is defined as (Wet weight of sample– Dry weight of sample)/Dry weight of sample. 
Similarly, scaffold degradation with and without modification was analyzed in the presence of 
Collagenase I. Collagenase I (Worthington Biochemical Corporation) was dissolved in PBS (pH 7.4) 
at a concentration of 0.5 mg/mL. Dry weights were measured for each sample, left to swell in 
PBS for 24 hours, transferred to the enzyme solution, and kept at 37oC.  Wet weights of samples 
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were measured at t=0, 24, 48, 72, and 96 hours; data is presented as a ratio of the sample wet 
weight at time t to the dry weight of sample. Additionally, material wettability with and without 
the addition of C18 molecules was evaluated through contact angle directly measured from the 
drop profile. Water droplets were pipetted onto material surface and an image was taken of 
liquid-solid interface. The angle at this interface was measured using ImageJ angle tool. All 
measurements done in triplicate for each material.   
 
2.5 Human Bladder Epithelial Cell and Fibroblast Proliferation 
 
Human Bladder Fibroblast cells (hBFCs) were obtained from ATCC and cultured in MEM + 
10% FBS + 1% P/S (Gibco). These cells were cultured until passage 4 prior to experimental use 
with cell culture medium exchanged every 2 days. Human Bladder Epithelial Cells (hBECs) were 
purchased from ATCC and cultured in Prostate Epithelial Cell Basal Medium supplemented with 
Corneal Epithelial Cell Growth Kit (ATCC). These cells were cultured until passage 3 on Poly (L-
Lysine) (Sciencecell) coated cell culture flasks with cell culture medium exchanged every 2-3 days. 
Unmodified and C18-modified dECM scaffold were cut into 7-mm diameter scaffolds 
using a biopsy punch and left to swell in PBS overnight. Samples were then submerged in 0.1 M 
NaHCO3 for 24 hours. This was then followed by sterilization using a peracetic acid treatment 
(0.2% peracetic acid, 4% ethanol) for 4 hours followed by 3 PBS washes of 1 hour each. Once 
samples were placed in designated wells of 96 well plate, 200 µL of complete media was added 
to each well for overnight incubation prior to cell seeding.  
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hFBCs at passage 4 and hBECs at passage 3 were detached with trypsin (0.25%, 3 mL per 
T25 flask), spun down at 1000 rpm for 5 minutes, and resuspended in media to approximately 
4x105 cells/mL. Approximately 2000 cells or 5 µL of the cell suspension were added to 150 µL of 
fresh media in each well and cultured for 1, 3, and 5 days at 37oC, 5% CO2 to evaluate cell-material 
interactions through direct contact. Media was exchanged every day. Cell number was evaluated 
at each time point using the CellTiter-Glo 3D Cell Viability assay (Promega) according to 
manufacturer’s instructions.  
 
2.6 Immunomodulation in vitro 
 
2.6.1 Monocyte to macrophage differentiation 
 
Monocyte culture, differentiation and macrophage polarization were performed in 
accordance to an earlier published protocol by Zarif et al31. Human THP-1 monocytes (ATCC) were 
cultured in RPMI-1640 medium + 10% FBS + 1% P/S. Monocytes were counted every 3 days to 
ensure the cell density remained between 0.2-1.0 x 106 cells/mL. Monocytes were cultured until 
passage 12-14 prior to experimental use. dECM samples (control and modified) were prepared 
in a similar manner to fibroblast adhesion and proliferation studies. After sterilization and 
subsequent washing, samples were placed in designated wells of a non-tissue culture treated 24-
well plate with 500 µL of RPMI-1640 + 10% HI-FBS + 1% P/S and incubated overnight prior to cell 
seeding. 
Monocytes were collected and spun down at 1000 rpm for 5 minutes then resuspended 
in RPMI-1640 + 10% HI-FBS + 1% P/S + 100 nM phorbol 12-myristate 13-acetate (PMA, 
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Peprotech). Approximately 0.2x106 monocytes from the cell suspension were added to each well 
with or without dECM samples and incubated for 24 hours to promote macrophage 
differentiation. Subsequently, media containing PMA was removed, replaced with media without 
PMA and cultured for an additional 48 hours prior to harvesting for further analysis. Macrophages 
cultured on tissue culture plate were used as reference for gene expression analysis. 
 
2.6.2 Macrophage Polarization  
 
Control 2D cultures were also seeded in wells not containing dECM samples. Additional 
2D cultures were biochemically stimulated into an “M1” or “M2” phenotype using the following 
treatment. In addition to PMA, 20 ng/mL of GM-CSF (M1) or M-CSF (M2) was added to the culture 
medium. After 24 hours, media was exchanged for RPMI-1640 + 10% HI-FBS + 1% P/S + 20 ng/mL 
GM-CSF or M-CSF and incubated for another 24 hours. Media was once again removed from 
macrophages and replaced with RPMI-1640 + 10% HI-FBS + 1% P/S + M1 or M2 polarizing 
cytokines obtained from Peprotech: specifically, 20 ng/mL LPS (Sigma), IFN-, GM-CSF and IL-6 
for M1 polarization and 20 ng/mL of IL-4, Il-13, M-CSF and IL-6 for M2 polarization. Macrophages 
were left to incubate in cytokine-enriched media for 72 hours prior to harvesting for further 
analysis. 
 
2.6.3 Gene Expression by RT-qPCR 
 
Relative gene expression levels were assessed for harvested samples 48 hours after PMA 
removal. 500 µL of TRIzol (Invitrogen) added to each well, triturated and incubated for 5 minutes. 
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TRIzol solution and ECM scaffold sample were transferred to centrifuge tube and kept at -80oC 
for at least 24 hours. Samples were later thawed to RT and chloroform extraction performed for 
total RNA isolation. In brief, 100 µL of chloroform (Sigma) was added to each tube and the 
solution was shaken vigorously for 15 sec followed by a 3-minute incubation and centrifugation 
at 12000g for 15 min at 4oC. The upper phase was collected and 250 µL isopropanol (Sigma) to 
precipitate RNA, incubated for 10 min and centrifuged at 12000g for 10 min at 4oC. The 
supernatant was removed, followed by two pellet washes using 75% EtOH (Sigma). RNA Pellets 
were air-dried and resuspended in nuclease-free water. Total RNA content measured using the 
Nanodrop One spectrophotometer (Thermofisher). RNA was subjected to RT-qPCR using primers 
specified for gene of interest and AgPath-ID One step RT PCR Universal Mix (Thermofisher) in a 
total volume of 12 µL per reaction. Samples were run in triplicate in a 384-well plate along with 
the housekeeping gene as controls. RT-PCR was performed using comparative CT Applied 
Biosystems at the following cycle conditions: Hold at 45°C for 10 min and at 95°C for 10 min 
followed by 40 cycles of denaturing at 97°C for 2 seconds and annealing at 60°C for 30 seconds 
each cycle. A delta delta CT method was used to analyze the data points. The following genes 
were assessed using TaqMan’s RT-qPCR primers/probe set: Transforming growth factor 1 
(TGF1), tumor necrosis factor  (TNF), CD86, CD163, CD68, and ubiquitin C (UBC) as the 








2.7 Biocompatibility in vivo 
 
2.7.1 Subcutaneous implantation 
 
Animal studies were performed in accordance to protocols approved by the Johns 
Hopkins University Hospital Animal Care and Use Committee. Sprague Dawley white rats (2 male, 
2 female – 8 to 12 weeks) were anaesthetized using isofluorane and 4 samples (5mm x 5mm size) 
of control dECM and modified dECM samples were grafted in the anterior ventral side of the rats. 
Incisions were cut on the dorsal section through the skin and scaffolds were implanted over the 
muscle under the skin. The incisions were sutured using Surgipro II monofilament polypropylene 
6-0 (Covidien). The rats were then split into two groups by time point, 7 days and 21 days 
respectively. At each time point, the rats were sacrificed, and the grafts harvested for histological 
analysis. 
 
2.7.2 Histological and Immunostaining  
 
Haematoxylin and eosin (H+E) staining was used to evaluate cell infiltration and Masson’s 
trichrome staining was performed to observe collagen content over time. All staining procedures 
were performed on formalin fixed, paraffin embedded tissues. Tissues were sectioned at 6 m 
thickness and placed on glass microslides. H+E and Masson’s trichrome staining was performed 
by a research specialist at the Department of Pathology, Johns Hopkins University. Images taken 
at 20x magnification were processed using ImageJ to determine number of cells/mm2 in the 
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center of the scaffold at each time point and thickness of collagen deposition at the biomaterial-
muscle interface at Day 21. 
 
2.8 Statistical analysis  
 
Unpaired t-test with Welch’s correction was performed to determine and statistical 
significance in mean values unless stated otherwise (n=3). Statistically significant values (p<0.05 




3 Results  
 
3.1 Mechanical Testing 
 
The mechanical properties of all unmodified dECM scaffolds, samples modified with C18 
aliphatic chains for 1 h and 2 h, as well as thermally denatured samples were evaluated through 
uniaxial tensile testing; rabbit bladder tissue was also tested for comparison. From tensile curves 
(Figure 1 depicts representative sample curves), peak values, elastic moduli and toughness were 
calculated and are summarized in Table 1. Rabbit bladder tissue exhibited a peak stress of 0.48  
0.2 MPa and achieved 122  38% elongation at this point; thus, a reference point of 100% 
elongation at 0.4 MPa was used to compare modified dECM samples to native bladder tissue in 
order to evaluate any changes in material elasticity.  
In general, the characteristic J-curve of viscoelastic materials was maintained for both 
modified and denatured materials (Figure 1). Modified porcine SIS showed considerable 
improvement in compliance at low stress values. The material elongation achieved at 0.4 MPa   
increased from 15% for unmodified SIS to approximately 45% for both C18-modified scaffolds 
tested (Figure 1B). All modified SIS scaffolds showed reduced elastic moduli from 0-20% and 0-
100%, indicating higher compliance. Longer reaction time increased material toughness and 
reduced compliance. A higher variability in peak stress was observed with minimal change in 
material toughness relative to the control: 846  158 J/m3 for unmodified, 761  67 J/m3 for 1 h 
reaction and 832  333 J/m3 for 2 h reaction. In contrast, thermally denatured samples had a 
toughness of 647  684 J/m3 . 
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Modified porcine UBM displayed elongated J-curves (Figure 1C), further characterized in 
Table 1. The 1 h modified UBM had a lower elastic modulus at both 20% and 100% strain, 1.35  
0.47 MPa and 1.87  0.43 MPa respectively, compared to unmodified UBM with 2.03  1.04 MPa 
and 3.11  0.43 MPa. The largest peak strain was achieved by the 2 h C18 modified UBM; 
however, only the 0-100% elastic modulus was reduced at 1.64  0.21 MPa. Thermal 
denaturation severely compromised material integrity as seen in the 6-fold reduction in 
toughness (51  14 J/m3). C18 modification of UBM resulted in moderate, but insignificant, 
increase in material toughness. 
 Bovine pericardium benefited the most from the incorporation of hydrophobes with an 
overall reduced peak stress ( 2.86  1.0 MPa for unmodified, 1.62  0.4 MPa for 1 h reaction time 
and 1.23  0.4 MPa for 2 h reaction time) and at least a 1.5-fold increase in strain achieved at 
peak stress (197  33% for unmodified, 333  55% for 1 h reaction time and 409  89 % for 2 h 
reaction time). At 0.4 MPa, unmodified bovine pericardium reached a 40% strain while samples 
modified with C18 for 2 hours reached 125% strain, a value very similar to rabbit bladder tissue 
(Figure 1D). The thermally denatured material exhibited improved distensibility that was on par 
with modification; a drastic decrease in overall toughness from 290  257 J/m3 to 84  33 J/m3 
called material stability into question. Aliphatic chain modification also reduced the variability 
reported in control pericardium toughness: 355  178 J/m3 for a 1 h reaction and 310  159 J/m3 
for a 2 h reaction. 
Bovine dermis also responded well to aliphatic chain modification. A modest increase in 
strain at 0.4 MPa (80% for unmodified, 110% for 1 h C18-modified, 140% for 2 h C18-modified) 
resulted in values more similar to bladder tissue (Figure 1E). Higher overall toughness values of 
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395  138 J/m3 for unmodified, 1071  844 J/m3 for 1 h reaction time and 636  139 J/m3 for 2 h 
reaction time indicated a vast increase in material strength. Interestingly, the properties of 
bovine dermis were heavily affected by thermal denaturation, displaying very mechanically weak, 
gelatin-like behavior with peak stress values of 0.09  0.1 MPa and toughness of 3  2 J/m3. 
Unmodified human dermis displayed a more viscoelastic curve than other dECM scaffolds 
tested (Figure 1F). The largest final elongation of all materials was achieved with the 2 h modified 
human dermis at 673  198% while unmodified human dermis had a final strain of 417  106% 
and a moderate increase was observed with human dermis modified with C18 for 1 hour (580  
78%). Interestingly, the final elongation of thermally denatured human dermis was on par with 
the 2 h modified samples at 648  150%. C18 modification improved the elongation as well as 
resulted in a higher peak stress. Reaction time did not have a significant effect on human dermis 
mechanical properties. The elastic moduli of modified material were found to be similar to those 
of bladder tissue. Thermally denatured human dermis appeared to be more intact compared to 
other dECMs after the same modification as demonstrated by its capacity to elongate 528  139% 
at peak stress of 4.06  0.8 MPa. Overall, C18 modified human dermis improved material 
toughness and stiffness to more closely match bladder values. 
 In general, C18 modification was found to not only improve scaffold elasticity for all 
dECMs included in this study, but also improve material strength overall. These improvements to 
the mechanical properties of naturally derived scaffolds address a primary concern for bladder 
tissue regeneration that has been previously overlooked, specifically the poor distensibility found 
to be common in dECMs.
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Table 1. Summary Values from uniaxial tensile testing: Uniaxial tensile testing was performed at constant strain rate of 1.0 mm/min. 
Peak stress and strain, final elongation achieved, elastic modulus calculated from 0 to 20% and from 0 to 100% strain shown. The area 




dECM Modification Peak Strain Peak Stress Final Strain 0-20 % E 0-100% E Toughness 
    % MPa % MPa MPa J/m3 
    Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  Mean  SD  
Rabbit Bladder   122 38 0.48 0.2 224 145 0.53 0.35 0.34 0.10 67 61 
  Unmodified 194 49 5.18 0.7 315 49 1.82 1.20 3.13 1.04 846 158 
Porcine C18 1 h rxn  317 73 3.98 0.4 370 57 0.96 0.82 1.09 0.49 761 67 
SIS C18 2 h rxn 311 24 4.92 2.4 343 37 1.34 0.82 1.26 0.69 832 333 
  TD 165 70 5.09 2.9 222 85 0.79 0.48 2.90 0.73 647 684 
  Unmodified 101 23 3.75 0.8 145 18 2.03 1.04 3.11 0.43 261 70 
Porcine C18 1 h rxn  170 24 3.23 0.1 206 61 1.35 0.47 1.87 0.43 321 87 
UBM C18 2 h rxn 191 29 2.97 0.4 209 27 2.20 0.74 1.64 0.21 329 79 
  TD 136 11 0.69 0.1 177 38 0.25 0.12 0.48 0.14 51 14 
  Unmodified 197 83 2.86 1.0 280 113 0.39 0.37 0.74 0.11 290 257 
Bovine C18 1 h rxn  333 55 1.62 0.4 426 101 0.49 0.21 0.46 0.15 355 178 
Pericardium C18 2 h rxn 409 98 1.23 0.4 461 110 0.42 0.27 0.35 0.07 310 159 
  TD 323 115 0.47 0.1 441 160 0.12 0.02 0.13 0.09 84 33 
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  Unmodified 411 96 1.65 0.3 499 74 0.17 0.05 0.31 0.13 395 138 
Bovine C18 1 h rxn  519 255 2.95 1.5 567 271 0.54 0.53 0.63 0.33 1071 844 
Dermis C18 2 h rxn 496 78 2.19 0.4 558 101 0.48 0.58 0.53 0.43 636 139 
  TD 35 14 0.09 0.1 91 23 0.17 0.05 0.01 0.00 3 2 
  Unmodified 289 81 2.16 1.0 417 106 0.05 0.03 0.24 0.16 339 143 
Human C18 1 h rxn  447 36 3.62 0.4 580 78 0.44 0.36 0.45 0.28 996 260 
Dermis C18 2 h rxn 523 47 3.33 0.5 673 198 0.34 0.07 0.39 0.12 1208 742 
  TD 528 133 4.06 0.8 648 150 0.02 0.01 0.04 0.02 1100 232 










Figure 1. Uniaxial tensile strength of control and modified dECM: Tensile tests were evaluated 
at room temperature with constant strain rate of 1.0 mm/min. Rabbit tissue bladder (A) was 
tested for comparison. Representative tensile stress vs. strain of porcine SIS (B), porcine UBM 
(C), bovine pericardium (D), bovine dermis (E),and human dermis (F) are shown as follows: 
dECM scaffolds(unmodified ⎯ ), dECM modified with C18 molecules for 1 hour (C18 1h rxn − 
− ), dECM modified with C18 molecules for 2 hours (C18 2h rxn ⎯ •• ) and thermally denatured 




3.2 Swelling and Enzymatic Stability 
 
The effect of aliphatic chain modification and thermal denaturation of dECM scaffolds on 
their swelling was investigated at 37oC (Figure 2A-E), as well as on their degradation profiles in 
the presence of 0.5 mg/mL Collagenase I (Figure 2F-J). In general, the addition of C18 molecules 
had no significant effect on the swelling profile at t=0, 1, 2, 3, 4, 6 h for all materials tested. 
Scaffold modification had no significant effect on the swelling ratio over time for porcine SIS. 
Differences in the swelling ratio were observed at t=24 h in porcine UBM, bovine pericardium, 
and human dermis. Thermal denaturation resulted in an increased swelling ratio for porcine UBM 
while C18 modification resulted in similar profiles for both reaction times tested; at t=24 h, a 
lower swelling ratio of 91   16% was observed for 1 h reaction time while samples modified for 
2 h had a swelling ratio of 160   59% (Figure 2B). Bovine pericardium and bovine dermis scaffold 
behavior changed significantly upon thermal denaturation with much higher swelling ratios 
compared to other samples at all time points. Thermally denatured bovine pericardium achieved 
a final swelling ratio of 617   38% at t= 24 hours compared to 276   16% for the unmodified 
scaffold (Figure 2C). Material degradation was observed for thermally denatured bovine dermis 
(Figure 2D), as shown in the swelling ratio decline between 6 h (430   51%) and 24 hours (160   
110%). In contrast, thermal denaturation did not affect swelling over time for human dermis; 
C18-modified scaffolds showed slight reduction of water intake relative to unmodified human 
dermis. Thus, the addition of C18 aliphatic chains did not significantly affect material swelling 
over time and modified scaffolds were able to maintain structure at a physiologically relevant 
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temperature. Heat exposure resulting in protein denaturation was found to negatively affect 
dECM thermal stability. 
 Across all dECM scaffolds tested, with the exception of human dermis, both unmodified 
and thermally denatured samples exhibited complete degradation within 24 hours. C18-modified 
SIS samples were able to withstand exposure to Collagenase I for over 96 h with little change in 
weight. Porcine UBM modified with C18 molecules for 2 h was the only sample of UBM to 
demonstrate delayed digestion. Relative to other tissue sources, bovine pericardium exhibited 
the highest degradation across modified and unmodified. However, while unmodified and 
thermally denatured had been completely digested within 24 h, some material was salvageable 
for wet weight measurements for C18-modified scaffolds. Longer reaction time improved 
material stability, most noticeably for porcine UBM with wet weight to dry weight ratio of 2.1  
0.43 after 24 h and bovine pericardium at a ratio of 1.5  1.0 after 24 h of enzymatic digestion. 
Bovine dermis exhibited similar behavior as porcine SIS, with a 25% reduction in wet weight loss 
by t=96 h. Human dermis samples exhibited the highest resistance to collagenase I with the 
addition of C18 chains further improving collagenase resistance; heat denaturation resulted in 
steady degradation of the dECM over time.  
Overall, the addition of aliphatic chains improved resistance to protease degradation while 
maintaining a similar swelling profile for all tissue types included in this study. The findings of this 
experiment indicate that C18 modification may serve to delay material degradation in vivo and 
support the slow process of urothelium regeneration for a longer period of time.  Based on this 
information, in vitro and in vivo studies were conducted on best performing modified material 
and unmodified dECM. A one-hour reaction time was chosen for porcine SIS and human dermis, 
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Figure 2. Evaluation of swelling behavior and resistance to enzymatic degradation with and 
without aliphatic chain modification: Swelling Ratio of unmodified and modified dECM 
scaffolds at 37oC, pH 7.4 (A-E) Groups shown for each dECM are as follows: dECM scaffolds 
(unmodified ⚫), dECM modified with C18 molecules for 1 h (C18 1h rxn ◼), dECM modified 
with C18 molecules for 2 hours (C18 2h rxn ) and thermally denatured dECM (65oC 2 h ). 
Weight of unmodified and modified dECM scaffolds remaining in 0.5 mg/mL collagenase I was 
also measured over time (F-J). Groups shown for each dECM are as follows: dECM scaffolds 
(unmodified   ), dECM modified with C18 for 1 h (C18 1h rxn  ), dECM modified with C18 
for 2 h (C18 2h rxn   ) and thermally denatured dECM (65oC 2 h  ).   
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3.3 Surface Hydrophobicity and Direct Cell Adhesion 
 
Surface hydrophobicity was evaluated before and after modification using contact angle 
measurements (Figure 3A). All dECM scaffolds tested showed an increase in surface 
hydrophobicity after the addition of aliphatic chains, as expected. Unmodified porcine SIS was 
the only dECM studied to display hydrophilicity (Contact angle < 40o); after 1 h modification, SIS 
shifted toward moderate hydrophobicity (48o < Contact angle < 62o)32.  
Interestingly, human bladder fibroblast growth was highest in direct contact with control 
porcine SIS scaffolds contact at 4.3  1.8 fold increase in cell number by Day 5 (Figure 3B). 
Modified porcine SIS showed initial cell adhesion support, but no significant change in cell 
number was observed over time. Cell growth was also evaluated for human bladder epithelial 
cells and THP-1 activated macrophages on porcine SIS scaffolds to observe the effect of increased 
hydrophobicity on different cell types (Figure 3C). Macrophage adhesion did not differ 
significantly between control and modified SIS materials. In contrast, epithelial cells attached 
preferably to the modified porcine SIS scaffold. Epithelial cell behavior was also observed over 
time for all scaffolds (Figure 3D). Porcine SIS control samples initially allowed for epithelial cell 
adhesion at t=24 h; growth was not supported as shown with stagnant or lower cell numbers at 
t=72 h and 120 h.  
Unmodified materials that display moderate wettability (namely porcine UBM, bovine 
pericardium and human dermis) were classified as extremely hydrophobic after the addition of 
aliphatic chains. Unmodified UBM and pericardium also had some ability to support fibroblast 
adhesion over time. The number of cells did not change over time for UBM considerably over 
time; a 3.3  0.8 -fold increase in cells from initial seeding (N/N0) for bovine pericardium indicated 
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that the material is better able to sustain fibroblast growth. Increased hydrophobicity reduced 
cell adhesion capacity for both scaffolds; this is more noticeable at 72 h and 120 h where few, if 
any, cells are detected. This behavior was not consistent with epithelial cells. Initially, few cells 
are found on unmodified Porcine UBM (N/N0 = 0.06  0.05); cell growth is delayed with N/N0 
marginally increasing to 1.3   0.9. Initial cell values were comparable for modified UBM scaffolds, 
with substantially less recovery in cell number observed by 120 h at N/N0 = 0.20   0.08. Epithelial 
cells adhered well to bovine pericardium control samples (N/N0 = 1.2  0.2 at t = 24 h); however, 
a gradual decrease was observed over time. The number of cells did not change over time for 
C18-modified bovine pericardium samples.  
Although human dermis scaffolds were found to have comparable wettability to porcine 
UBM and bovine pericardium, neither control nor modified samples supported fibroblast growth. 
Epithelial cell adhesion was moderately improved relative to fibroblasts with N/N0 = 0.10  0.01 
and N/N0 = 0.12  0.04 for control and C18-modified samples, respectively.  Bovine dermis was 
found to be the most hydrophobic material, with the highest contact angle of all ECM scaffolds 
tested, both before (77  8o) and after C18 modification (102  5o). Regardless, fibroblast 
adhesion is detected on day 1 and a 2.5  0.9-fold increase in cell number is observed in bovine 
dermis control samples. Cell growth is considerably delayed on modified bovine dermis. Similarly, 
epithelial cell adhesion was maintained at t=24 h and t=72 h on control bovine dermis samples 
while few cells adhered to modified bovine dermis at all time points.  
While the ability to support cell growth varied by dECM source, the increased 
hydrophobicity of C18-modified materials caused reduced bladder fibroblast proliferation over 
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time. Moderately hydrophobic materials supported bladder epithelial cells; few epithelial cells 
were detected on extremely hydrophilic or hydrophobic dECM scaffolds.  
 
Figure 3. Hydrophobicity and cytotoxicity in vitro: A) Surface hydrophobicity assessed through 
direct measurement of water-material contact angle. C18 modified samples exhibit higher 
contact angle, signifying increased hydrophobicity. B) human bladder fibroblast growth 
determined through luciferase assay at t= 24, 72, 120 h for control dECM and modified dECM as 
chosen based on mechanical and physical properties. C) The effect of C18 modification on cell 
adhesion was compared between SIS control and modified for activated macrophages (M0), 
human bladder fibroblasts (hBFCs) and human bladder epithelial cells (hBECs) at t=72 h. D) 
human bladder epithelial cell growth was also determined through luciferase assay at t= 24, 72, 
120 h for control and modified dECM. All cell numbers were normalized to initial cell seeding 
density (2000 cells/well).  
 
25 
3.4 Immunomodulation in vitro 
 
The short-term immune response was investigated in vitro by differentiating THP-1 
monocytes to macrophages in the presence of control or modified dECM scaffolds, followed by 
RNA isolation and gene expression analysis for CD68 (M0 surface marker), CD86 (“M1” surface 
marker), CD163 (“M2” surface marker), TNF- (pro-inflammatory cytokine), and TGF- (anti-
inflammatory cytokine).  
Biochemically stimulated macrophages were also evaluated for expression of the above 
genes. Interestingly, differences in surface marker expression were noticeably observed between 
polarized macrophages and unpolarized macrophages (Figure 4). M-CSF + LPS + IL-6 + IFN- 
stimulation to generate M1 polarized macrophages caused a significant increase in CD68 and 
CD86 expression with no change in CD163 or TNF-. A decrease in TGF- was observed. GM-CSF 
+ IL-4 + IL-13 + IL-6 stimulation for the M2 polarized macrophages showed no change in CD68 
expression, reduced CD86, TNF- and TGF- as well as very high expression of CD163. In contrast, 
significant changes between different tissue sources as well as between control and C18-
modified scaffolds were observed in cytokine expression with a reduced or minimal effect on 





The normalized fold change of expression for each gene of interest and dECM 
experimental group relative to 2D M0 expression is shown in Figure 5. Macrophages cultured 
with unmodified porcine SIS maintained expression levels of CD163 and TNF- and 
downregulated expression of CD68, CD86 and TGF- relative to 2D controls, suggesting a “mixed” 
macrophage phenotype. CD68 expression levels comparable to 2D controls was found in 
modified SIS samples with no change in CD86 and slight increase in CD163 compared to control 
SIS samples. TNF- expression was reduced in C18-modified SIS while TGF- expression levels 
Figure 4. Surface Marker expression of biochemically polarized macrophages:  Gene expression 
analysis using RT-qPCR of macrophages exposed to pro-inflammatory (M1) or anti-inflammatory 
(M2) cytokines. Biochemically stimulated macrophages showed upregulation in corresponding 
surface marker (M1-CD86 and M2-CD163) compared to control (M0) but no significant differences 
observed in cytokine expression. 
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increased compared to control SIS (Figure 5), indicating a shift towards an M2-like phenotype. 
Porcine UBM displayed similar behavior to SIS in that a downregulation of markers indicative of 
pro-inflammatory phenotype was observed in modified samples compared to control. CD68 
levels were maintained across control UBM, modified UBM and 2D controls. Macrophages 
incubated with control UBM showed a high increase in CD86 and a slight increase in CD163 
compared to 2D controls; CD86 levels were reduced in C18-modified porcine UBM while CD163 
levels were comparable to that of unmodified UBM. Macrophage exposure to scaffolds in vitro 
resulted in an increase in cytokine expression levels. TNF- expression was reduced upon 
aliphatic chain modification while TGF- was somewhat upregulated. 
Modulation of the THP-1 macrophage phenotype was seen most noticeably with bovine 
pericardium. CD68 expression was moderately upregulated in both control and modified 
scaffolds; higher expression was found for macrophages cultured with modified bovine 
pericardium. CD86 expression was unchanged in both samples; CD163 levels were higher than 
control 2D macrophages and macrophages exposed to other dECMs. TNF- expression was 
maintained and higher TGF- was observed in control bovine pericardium; in contrast, expression 
of TNF- in C18-modified samples was significantly downregulated relative to both control 
bovine pericardium and 2D controls. TGF- expression was also upregulated to a higher degree 
in modified bovine pericardium compared to its unmodified counterpart. 
Macrophage differentiation was not well supported on dermis samples. Bovine dermis 
samples showed downregulation of all surface marker expression but very high TNF- expression 
and some expression of TGF-. Unmodified bovine dermis elicited very high response in TNF- 
production, although minimal CD86 marker expression was detected. TNF- expression was 
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reduced, and TGF- levels were maintained with the incorporation of hydrophobes. A similar 
response was observed for human dermis dECM in terms of surface marker expression levels. 
However, minimal expression was detected for TNF- in both control and modified human 
dermis samples. TGF- expression was upregulated in control human dermis compared to 2D M0 
controls but, unlike all other dECMs, a downregulation in TGF- levels was seen in modified 
human dermis.  
In general, gene expression of key macrophage phenotype markers varied across its 
spectrum by tissue source. However, C18 modification was shown to modulate macrophage 
response to the biomaterial by minimizing a severe inflammatory response and causing a shift 
towards a pro-regenerative (M2) phenotype. This change was observed primarily in changes in 







3.5 Biocompatibility in vivo 
 
Unmodified and C18 modified dECM scaffolds were subsequently grafted in male and 
female rats subcutaneously to further investigate the effect of aliphatic chain incorporation on 
cell-material interactions and material degradation in vivo. Scaffolds were harvested at Day 7 and 
Day 21 to observe any changes in host reaction over time. Cell infiltration was evaluated through 
H&E staining (Figure 6) qualitatively and quantitatively at both timepoints. Masson’s Trichrome 
Figure 5. Macrophage polarization in vitro: Gene expression analysis using RT-qPCR of 
THP-1 macrophages exposed to unmodified and modified dECMs for 72 hours. Modified 
dECM showed decreased expression of pro-inflammatory genes (CD86, TNFA) while 
maintaining or upregulating expression of pro-regenerative markers (CD163, TGFB). CD68 
was included as indicator for the presence of macrophages. All material results relative 




staining was done to observe collagen content (Figure 7). Material degradation was assessed 
qualitatively at both time points and collagen deposition by surrounding fibroblasts at the 
biomaterial-muscle interface was evaluated quantitatively for Day 21 samples. Of note, 
differences in staining were observed in modified materials compared to control samples where 
C18 modification was easily observed as bright red tissues in samples stained with Masson’s 
Trichrome. During this process, tissues are stained first with acid dye that binds to acidophilic 
tissue components, such as the C18 molecules, followed by an additional acid wash where the 
“red” color is maintained for less permeable tissues33. 
Cell infiltration throughout the unmodified porcine SIS samples as well as blood vessel 
formation was seen by day 7 (Figure 6A). Continued cellular presence was observed in Day 21 
samples. This was confirmed in quantification of cells in the center of the material (3031 ± 1227 
cells/mm2 for Day 7 and 3099 ± 1819 cells/mm2 for Day 21). Female rats exhibited higher cell 
counts relative to male counterparts at both time points. Porcine SIS also exhibited fast 
degradation in vivo (Figure 7A).  Some newly deposited collagen was found in grafts harvested 
on Day 21; thickness of deposited layer measured to be 64 ± 33 m with male grafts exhibiting 
higher collagen amounts at the interface. C18 modification noticeably affected cell infiltration for 
porcine SIS. High cell accumulation was observed at the edges and in between layers of the 
biomaterial by Day 7 (4308 ± 1316 cells/mm2) relative to the control, although insignificant. 
Interestingly, samples grafted in male rats showed higher cell counts than female samples (Figure 
6B). By Day 21, nuclei were observed throughout the biomaterial and accumulation at the edges 
was no longer found. This is evident in reduced cell counts for modified SIS at this time (2522 ± 
557 cells/mm2). Cell infiltration was, therefore, not significantly changed by the addition of 
 
31 
hydrophobes in porcine SIS.  Material degradation rate was affected by hydrophobe 
modification, as seen in modified SIS samples shown in Figure 7A. The dECM was significantly 
more intact at Day 7 than control samples, with the bright red staining suggesting the presence 
of C18 hydrophobes in the scaffold. The surface modification was not observed in Day 21 
modified SIS samples; although, a dense blue layer of collagen was seen. Thickness of this layer 
was found to be 67 ± 41 m, comparable to control samples at this time point (Figure 7B).  
Porcine UBM also experienced cell infiltration throughout the material at 3894 ± 1155 
cells/mm2, which was relatively intact at Day 7; cell presence was still found at the Day 21 time 
point, along with blood vessel formation in Figure 6A. Similar to porcine SIS, a slight decrease in 
cell counts was observed at Day 21 (2872 ± 1128 cells/mm2). Male and female rats showed similar 
response in terms of cell infiltration in the biomaterial. A thick, lightly packed layer of collagen is 
easily seen in Trichrome stains of unmodified UBM in Figure 7A. A divergence in the amount of 
collagen deposited at the interface between males and females was observed by Day 21 where 
the thickness of the collagen layer was 2.5-fold lower in females than males (Figure 7B). The 
average thickness was determined to be 83 ± 47 m, much higher than all other dECM samples. 
A high accumulation of cells is once again observed at the periphery of the C18 modified porcine 
UBM at Day 7 in Figure 6A; however, few cells are found beyond the interface into the center of 
the biomaterial at 290 ± 282 cells/mm2. This is in stark contrast to the behavior observed in 
control samples. This delayed material breakdown and cell infiltration is confirmed by the 
increased cell presence in Day 21 modified samples (5217 ± 2618 cells/mm2), a significant 
increase compared to control samples. Surface modification is very clearly bright red in modified 
Porcine UBM samples in Figure 7A. Laminated layers of porcine UBM were also more clearly 
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observed here. The bright red of C18-modified surface was no longer evident by Day 21. Newly 
deposited collagen was found (thickness of 67 ± 41 m); this was lower than the control 
counterpart, but the difference was not statistically significant. Once again, grafts implanted in 
females were found to have less collagen deposited at the interface, 3-fold lower than male grafts 
(Figure 7B).  
Cell infiltration was seen throughout the dECM scaffold with high vessel formation seen 
at Day 7 (Figure 6A). Number of cells per mm2 of biomaterial was comparable to other dECMs at 
2696 ± 1800 cells/mm2. High variability was observed between male and female samples with 
3.5-fold decrease in cell counts for female samples relative to male samples, as shown in Figure 
6B. Cell infiltration at day 21 is comparable to Day 7 at 2534 ± 1315 cells/mm2. Bovine 
pericardium rapidly degraded in vivo; This is observed observed in grafts harvested on Day 7 and 
Day 21 (Figure 7A). Interestingly, only a thin layer (33 ± 13 m) of tightly packed collagen was 
observed Day 21 (Figure 7B). Similar to the control, rapid material degradation was also observed 
for modified Bovine Pericardium by Day 7 in Figure 7A. A significant increase was observed in cell 
infiltration relative to the control (3712 ± 1724 cells/mm2), with female grafts displaying a 3-fold 
increase in cells/mm2 than male grafts. This value was found to be lowered considerably by Day 
21 at 1409 ± 698 cells/mm2 with less of a difference in response between male and female rats 
at this time (Figure 6B and 6C). Collagen deposited by the host was found in Day 21 samples and 
a measured thickness of 61 ± 8 m is shown in Figure 7B. This difference is significant, a 2-fold 
increase in the thickness compared to the control samples. 
Bovine dermis scaffolds showed delayed cell infiltration in the center with the majority of 
cells found at the host-material interface with only 748 ± 436 cells/mm2 at day 7; this was true 
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for grafts placed in male and female rats. By Day 21, intact biomaterial was still seen with some 
cell presence in the material itself; although, this was not seen evenly throughout the material 
(Figure 6A). This qualitative observation was confirmed quantitatively with 1644 ± 1221 
cells/mm2 found for unmodified bovine dermis in Day 21 samples (Figure 6C). Measurements 
made from female samples were once again 3-fold higher than male values. Masson’s Trichrome 
staining of unmodified bovine dermis samples showed little degradation at Day 7 and Day 21 
(Figure 7A). Collagen fibrils were found at the muscle interface where the highest cell presence 
was seen on Day 7; by Day 21, these fibrils appeared to be more densely packed. Measurements 
of the collagen layer thickness determined the thickness of collagen layer to be 55 ± 21 m on 
Day 21. High cell recruitment to the biomaterial edges was also seen for C18-modified bovine 
dermis. In this case, cell infiltration was calculated to be significantly higher in the modified dECM 
compared to the control for both time points studied and maintained over time (3184 ± 1314 
cells/mm2 at Day 7 and 3448 ± 1604 cells/mm2 at Day 21). Aliphatic chain modification was 
apparent at the surfaces of modified bovine dermis samples on Day 7, as was the mainly intact 
dECM scaffold. Collagen found at the biomaterial edge was similar in structure to control 
samples. Some progression in biomaterial remodelling was observed in Day 21 samples, although 
much of the scaffold remained. The collagen layer deposited at the edge of C18-modified bovine 
dermis was more densely packed by Day 21, even to a greater extent than control scaffolds with 
collagen thickness measured to be 28 ± 5 m (Figure 7B), half the thickness of control samples. 
Variable cell infiltration was observed at the scaffold center of unmodified human dermis 
by Day 7 (1643 ± 1451 cells/mm2). No cells were found at the center of grafts implanted in 
females (as shown qualitatively Figure 6A) while a considerable presence was detected in male 
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samples, noted in Figure 6B. Cell presence is maintained with 1153 ± 590 cells/mm2 found at Day 
21. Female and male response was found to be similar at the later time point (Figure 6C). The 
unmodified human dermis scaffold appeared largely intact by Day 7 and no vessel formation was 
observed. By Day 21, progressed material degradation and some early vascularization could be 
seen and the thickness of deposited collagen layer was 57± 15 m; increased density of the 
deposited collagen layer between Day 7 and Day21 was evident qualitatively (Figure 7A). Again, 
modified samples elicit large accumulation of cells at the interface but reduced cell presence at 
the center (964 ± 1071 cells/mm2 for modified human dermis at Day 7). By Day 21, material 
degradation had progressed, allowing for a higher cell presence in modified human dermis 
scaffolds (1704 ± 428 cells/mm2). The characteristic bright red staining of C18 aliphatic chain 
presence was seen in stained Day 7 samples with the modified human dermis sample largely 
intact. Wavy fibrils of collagen different from the organization of collagen in the graft was 
observed. The thickness of collagen deposition at the interface by Day 21 had increased 
compared to control samples to 96 ± 37 m (Figure 7B). Biomaterial degradation and 
vascularization were also delayed as more of the dECM was present relative to unmodified 
human dermis.  
H+E and Trichrome staining showed that cell infiltration and biomaterial degradation was 
delayed in vivo for all tissue sources upon C18 modification at early time points, as suggested by 
earlier in vitro experiments. Cell-matrix interactions, including material remodelling and 
vascularization, was observed by Day 21 for both unmodified and modified scaffolds. The 
addition of hydrophobes did not appear to cause excess collagen deposition at the muscle-
material interface for SIS or UBM samples but did cause a significant increase for pericardium 
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and human dermis samples. Bovine dermis samples showed an overall reduction in collagen 
deposition upon modification, indicating that the effect may vary with tissue source. There was 
no evidence of graft rejection in the form of excess fibrosis or the formation of foreign body giant 












Figure 6. In vivo subcutaneous biocompatibility of C18-modified dECM scaffolds through 
cell-material interactions: A) H&E staining showed that cell infiltration to the center of 
dECM is delayed at Day 7 for modified scaffolds relative to control counterparts, cells 
present in center by day 21. Scale bar = 1000 m I=Interface M=Material V=Vasculature. B) 
Quantification of cells present in the center of dECM at day 7 confirmed reduced cell 
infiltration for modified grafts (o) compared to control (•), but this largely varied between 
male (black) and female rats (red). C) Quantification of cells present in the graft center at 
day 21 confirms larger presence of cells at later time points in modified grafts (o) compared 














Figure 7. In vivo subcutaneous biocompatibility of C18-modified dECM scaffolds through 
collagen deposition: A) Trichrome staining showed collagen presence of dECM grafts at 
Day 7 and Day 21, as well as collagen deposited at graft-muscle interface (arrows) 
indicated by difference in organization Scale bar = 1000 m M= Material. B) Quantification 
of collagen deposited at the muscle interface at day 21 showed differences in thickness for 
modified grafts (o) compared to control (•); response varied between male (black) and 






4 Discussion  
 
Decellularized extracellular matrices have long since been established as attractive 
biomaterials for tissue regeneration due to their inherent biocompatibility; both xenogeneic and 
allogenic sources have been shown to integrate into the host environment with reduced immune 
complications and dECM composition naturally includes important bioactive cues to promote 
cell-scaffold interactions19. The C18-modified dECMs presented here address the mechanical 
shortcomings observed in preclinical studies using dECM for bladder tissue regeneration by 
improving material extensibility to better mimic native bladder tissue (Figure 1). Although several 
researchers have endeavoured to improve outcomes using chemically modified dECMs, this is 
the first attempt to improve various decellularized scaffolds’ ability to meet the bladder’s load-
bearing requirements. In the present work, we modified porcine SIS, porcine UBM, bovine 
pericardium, bovine dermis and human dermis by incorporating hydrophobes that act as 
transient crosslinkers to improve the viscoelastic dissipation at a molecular level and generate 
scaffolds of high toughness and compliance, in a manner similar to synthetic polymer and 
collagen scaffolds27,30 . 
The degree of modification, and as a result the mechanical properties, could be 
manipulated by reaction time (Figure 1). Soft tissues typically exhibit viscoelastic behavior1 and 
we found that the addition of hydrophobes maintained this profile. Noncovalent interactions 
with aliphatic chains may result in conformational changes in the proteins present in dECMs; we 
exposed unmodified dECMs to a denaturing temperature (65oC) in order to compare the partially 
denatured dECM to the unmodified and C18 modified samples. Porcine SIS, porcine UBM and 
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bovine pericardium are scaffolds of particular interest in reconstructive urology. Upon 
modification, all three dECMs exhibited increased compliance, as seen through the increased 
peak strain at a reduced peak stress relative to unmodified samples and elastic moduli closer to 
bladder tissue values (Table 1). Material toughness was not compromised but rather maintained 
or improved upon C18 addition for these materials. This is promising as it may extend the lifetime 
of these dECMs in vivo to act as support during the tissue regeneration process. Bovine dermis 
and human dermis samples also exhibited improvements in peak strain; however, peak stress, 
elastic moduli and toughness also all increased, indicating that aliphatic chain modification 
resulted in stiffer scaffolds for this tissue type (Table 1). Thermal denaturation also increased 
peak strain and reduced peak stress as well as elastic moduli; although, this was at the cost of 
drastically reduced material toughness values to those much lower than bladder tissue. Porcine 
SIS and human dermis are two exceptions to this observation, where peak stress and toughness 
were largely unaffected; this may be the result of the level of natural crosslinking present in these 
scaffolds. 
Hydrophobe addition did not affect the dECM’s ability to swell in an aqueous environment 
and allow for small molecule diffusion throughout the biomaterial, as the swelling profile and 
swelling ratio at 24 h were mostly unaffected by C18 modification at both reaction times (Figure 
2 A-E). As previously mentioned, the noncovalent interactions between aliphatic chains and 
collagen fibrils may result in protein conformational changes. Any changes in the swelling profile 
that would be caused by the opening of the collagen triple helix to a random coil configuration is 
likely balanced out with the introduction of hydrophobes in the modified scaffolds. We attributed 
changes in the swelling ratio for porcine UBM modified with C18 for 1 h to a separation of the 
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laminated layers observed, and subsequent loss of material, after prolonged swelling at 37oC. 
Thermal denaturation had a larger effect on swelling, with increased swelling ratios seen most 
noticeably in porcine UBM, bovine pericardium and bovine dermis samples but not in porcine SIS 
or human dermis samples similar to the trend observed during tensile testing. This behavior 
further supports the use of hydrophobic groups as crosslinked junctions to improve mechanical 
properties as it does not affect the scaffolds’ thermal stability in an aqueous environment.  
C18 modification greatly improved resistance to enzymatic degradation for all dECM 
types compared to unmodified and thermally denatured dECMs (Figure 2 F-J). The protease 
degradation profile over time could be tunable by adjusting the reaction time as seen in Figure 2 
G and Figure 2 H whereby a 2 h reaction time resulted in reduced material degradation over time 
compared to a 1 h reaction time for porcine UBM and bovine pericardium. In the case of UBM, 
the previously observed separation of laminated layers may have served to increase the surface 
area exposed to enzyme and cause more rapid degradation. These results further indicate the 
prolonged lifetime of the modified dECMs in vivo, addressing the secondary issue of rapid 
degradation of unmodified dECM scaffolds. 
Surface hydrophobicity has been shown to affect protein adsorption on biomaterial 
surfaces, and by extension, the adhesion of surrounding cell types as well as their differentiation 
in the case of immune cells34. Definitive conclusions about cell adhesion and preference for 
hydrophilic vs. hydrophobic surfaces are conflicting and differ between cell types. A number of 
reports have found fibroblast adhesion and proliferation to be higher on hydrophilic surfaces35–
37 while opposing results have been reported for monocyte adhesion to hydrophobic 
surfaces15,38. Moreover, epithelialization has been seen to take several weeks on hydrophilic 
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porcine SIS8, and corneal epithelial cell adhesion was not inhibited in vitro on hydrophobic 
surfaces37. 
Direct measurements of the surface contact angle confirmed that all dECM surfaces 
become more hydrophobic regardless of their initial affinity for water (Figure 3A). Fibroblasts 
showed much higher proliferation on control scaffolds, most noticeably on porcine SIS, bovine 
pericardium and bovine dermis, with the exception of human dermis (Figure 3B). All modified 
materials showed the ability to support cell adhesion; although, to a higher degree of variability. 
Delayed proliferation was observed with increased hydrophobicity, again with the exception of 
human dermis, that had minimal adhesion on both counts. Interestingly, macrophage adhesion 
was comparable between hydrophilic and hydrophobic surfaces (Figure 3C). While we observed 
a clear preference for hydrophilic surface for fibroblasts, this was not the case for bladder 
epithelial cells that preferred moderate hydrophobicity than either extremely hydrophilic 
surfaces or extremely hydrophobic surfaces. Delayed proliferation on modified materials further 
supports this observation. Unmodified bovine pericardium and bovine dermis were able to 
induce proliferation and epithelial cell performance was improved on human dermis samples 
over modified bovine dermis (Figure 3D). This suggests that extreme hydrophobicity may have a 
greater negative impact. Other properties of biomaterials such crosslinking degree, scaffold 
content and structure also play a role in cell migration and proliferation39. Since these factors 
varied across all dECMs and cell-material interactions are a result of a combination of these 
properties, future studies focused on characterizing cell behavior in vitro may include 
experimentation defining these properties in dECM in greater detail. Additionally, protein 
adsorption plays a strong role in cell adhesion and previous reports have shown that proteins 
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adsorb more on hydrophobic surface but also undergo a higher level of conformational change 
with increased surface hydrophobicity35. Proteins in complete media were allowed to adsorb 
onto dECM surface overnight; however, this may not be representative of the amount that may 
be adsorbed in vivo and cause difficulties in accurately evaluating material cytotoxicity in vitro.  
Macrophages are considered one of the first responders to the implant site and interact 
with implanted materials14,15. Cytokine production by macrophages and other cells regulate the 
phenotypic response from other immune cells. Because of their role in implant rejection, 
macrophages are frequently implemented to evaluate the short-term immunomodulatory 
capacity of scaffolds in vitro. A shift towards an “M2” phenotype is desirable in biomaterial design 
to reduce inflammation at the implant site and signal the formation of new tissue to surrounding 
tissue-resident cells40. This is an especially important consideration in the urinary environment 
where there is a high exposure to toxins. While previous studies have found that dECM is 
resistant to bacterial infection41, preclinical outcomes have reported inconsistent results due to 
graft contracture and inflammation from long-term exposure to urine8,17,24. We chose THP-1 
monocytes to observe the response from human immune cells. We differentiated the monocytes 
into macrophages and exposed the cells to either stimulating cytokines or dECM scaffolds, 
control or modified, to observe differences in macrophage phenotype behavior. The delivery of 
signalling cytokines resulted in stronger upregulation in key surface marker expression (Figure 4) 
while exposure to a foreign biomaterial causes a shift in cytokine production (Figure 5). TNF 
expression was substantially reduced in C18-modified dECM across all tissue sources, indicating 
a reduction in cytokine signalling for inflammatory immune cells (Figure 5). Increased TGF 
further indicated a shift towards a pro-regenerative phenotype. We observed changes in surface 
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marker expression towards an M2 phenotype to a lesser degree for most dECMs. We noticed a 
strong downregulation in the case of both unmodified and modified bovine and human dermis, 
indicating that these materials may not support macrophage differentiation in vitro. The 
incorporation of hydrophobes promoted CD68 and CD163 expression in modified bovine 
pericardium, the dECM that most strongly resembled rabbit bladder tissue in terms of mechanical 
properties. These results further support the use of C18 molecules to not only improve a 
scaffold’s mechanical properties but also mitigate a pro-inflammatory response from 
macrophages. A reduced inflammatory reaction may also be beneficial in the potential use of 
cell-laden modified dECMs to reduce the potential for adaptive immune cells attacking foreign 
cells that would be present at the implant site. 
The typical host response to a foreign body begins immediately upon implantation with 
protein adsorption, followed by immune cell infiltration and cytokine release over the course of 
the first week; subsequently, other cell types such as fibroblasts are recruited42. In the event that 
a biomaterial is not biocompatible (does not result in quick resolution of the initial inflammatory 
response), persistent infection and fibrous encapsulation is evident three to four weeks post-
implantation42,43.Changes in dECM composition can change the host’s foreign body response. 
Therefore, we evaluated the impact of aliphatic chain modification on the host’s behavior 
through subcutaneous implantation of unmodified and modified scaffolds by analysing cell 
infiltration, biomaterial degradation and collagen deposition at an early timepoint (Day 7) and 
later timepoint (Day 21). C18-modified materials showed delayed cell infiltration, except for 
modified bovine pericardium, with cells accumulating primarily at the interface on Day 7 (Figure 
6); this dissipates by Day 21 as cells are able to penetrate to the biomaterial center. This 
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observation is expected as degradation of the biomaterial is known to activate the immune 
system response, which begins with cell accumulation at the site upon protease digestion and 
material remodelling15,44. We found a highly varied gender-based response at Day 7 in terms of 
cells present per unit area at the center of biomaterial (Figure 6). This becomes less obvious by 
Day 21 in modified materials, with the exception of modified UBM and unmodified bovine 
dermis.  
Modified dECMs displayed reduced degradation compared to control in vivo when 
qualitatively evaluated through Masson’s Trichrome staining (Figure 7) similar to the enzymatic 
degradation test performed with Collagenase I. The thickness of the newly deposited collagen 
layer was quantified for samples harvested on Day 21 to further study the host response. 
Collagen deposition varied not only between dECMs but also between control and modified 
samples. Porcine SIS, porcine UBM and bovine dermis all exhibited thinner layers of collagen at 
the interface upon modification while modified bovine pericardium and human dermis had 
significantly thicker layers compared to controls. A previous study conducted by Kyriakides et al. 
measured the thickness of collagen layers for subcutaneously implanted biomaterials and found 
encapsulated samples to have thickness greater than 150 m45. It is noteworthy that no modified 
scaffold in this study had a reported thickness above 100 m. Although biomaterial degradation 
and cell infiltration were delayed, this did not appear to result in fibrotic capsule formation or 
graft rejection. Longer term studies may be required to see if fibrotic capsule formation is truly 
mitigated or simply delayed with the addition of hydrophobes.  
In summary, studies on cell adhesion and immunomodulation with modified and 
unmodified dECMs suggest that C18-modified dECMs may be suitable candidates for urologic 
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tissue regeneration. The addition of transient crosslinkers provides material strength and 
improves compliance to make dECMs more suitable for load-bearing applications.  Further in vivo 
studies in the urodynamic environment, where dynamic loading and toxin presence may have an 
effect on macrophage polarization42, cell infiltration and fibrosis formation would provide further 
clarity. Future directions may also include the addition of pre-adsorbed extracellular matrix 
molecules on C18-modified dECMs, thus combining mechanical properties mimicking native 






The work presented here outlines a simple methodology for the incorporation of aliphatic 
chains in decellularized extracellular matrices to improve their mechanical properties such that 
they are better suited for bladder tissue engineering. The addition of hydrophobes did improve 
material compliance to more closely mimic native bladder tissue and improve protease 
resistance without negatively impacting material swelling in physiological conditions. The 
inherent bioactive cues in dECM offer a 3D microenvironment that supports cell adhesion; 
increased hydrophobicity through C18 modification did result in delayed proliferation for primary 
bladder fibroblasts and epithelial cells in vitro, but cell infiltration was supported in vivo.  
Modified dECMs, most noticeably bovine pericardium, also displayed immunomodulatory 
capacity in vitro with localized macrophage polarization towards a pro-regenerative M2 
phenotype, which may improve preclinical outcomes for dECMs in a urodynamic environment. 
These promising results establish aliphatic chain modification as a viable strategy that tackles 
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